SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Two Hands Corp sold a $132,000 convertible promissory note (net funding $125,000) to Vanquish Funding Group, convertible into common stock at 75% of the lowest closing bid price during the 10 trading days prior to conversion. The unregistered sale was made under Section 4(a)(2) exemption to an accredited investor.
View raw filing on EDGAR →The filing discloses unregistered sales of equity securities under Item 3.02, involving the issuance of approximately 1.26 million shares of common stock (77,360 + 1,018,585 + 167,400) to existing preferred stockholders in exchange for preferred shares. The transactions rely on Section 3(a)(9) exemption and result in significant dilution to common shareholders. While structured as preferred-for-common exchanges rather than cash-raising private placements, the net effect is a material dilutive issuance of unregistered common equity.
View raw filing on EDGAR →The filing discloses an unregistered private placement of 216,537 shares of Series A Convertible Preferred Stock under Regulation D Rule 506(b), generating $2.1 million in gross proceeds. This is a classic dilutive equity issuance to accredited investors as part of an ongoing $200 million offering, filed under Item 3.02 which is the standard disclosure vehicle for unregistered equity sales. The convertible nature and scale of the offering make it material to investors assessing the company's capital structure and dilution.
View raw filing on EDGAR →On July 10, 2026, Baosheng Media entered into a securities purchase agreement with High West Partners LLC permitting the issuance of up to US$30,000,000 of ordinary shares at discounted prices (85–97% of VWAP depending on purchase type). This is a classic PIPE (private investment in public equity) arrangement—an unregistered equity issuance at a discount to market price that dilutes existing shareholders. The company must file a prospectus supplement to register the shares, and the investor has agreed not to short-sell during the agreement term, both hallmarks of dilutive equity financing.
View raw filing on EDGAR →Rithm Property Trust announced a public offering of common stock and a concurrent private placement by an affiliate of Rithm Capital, with net proceeds intended to fund the acquisition of a $951.1 million portfolio of multifamily transition loans.
View raw filing on EDGAR →Agenus entered into a Securities Purchase Agreement for a private placement of approximately $85 million in upfront gross proceeds plus up to $255 million upon warrant exercise, totaling up to $340 million. The company will issue 23,035,227 shares of common stock (or pre-funded warrants), Series A purchase warrants for 21,144,277 shares, and Series B purchase warrants for 33,797,214 shares to institutional investors including Commodore Capital, RA Capital, TCGX, Invus, and Ligand, representing substantial dilution to existing shareholders.
View raw filing on EDGAR →TOP Financial Group completed a private placement on July 9, 2026, issuing 214,431,222 Class A ordinary shares and warrants to purchase 428,862,444 additional shares to non-U.S. investors under Regulation S, raising $80 million in gross proceeds. This substantially dilutive issuance increased outstanding Class A shares from 27.1 million to 247.9 million, materially affecting existing shareholders' ownership percentages and the company's capital structure.
View raw filing on EDGAR →Greenfire Resources announced a rights offering of common shares for gross proceeds of at least $575 million at a subscription price not to exceed $6.74 per share (15% discount to VWAP), to be conducted on an unregistered basis pending prospectus filing. The offering is tied to financing the Connacher Oil acquisition.
View raw filing on EDGAR →The 6-K discloses entry into securities purchase agreements on July 2, 2026, whereby Mint Incorporation Limited issued 4,310,350 Class A ordinary shares to new and existing investors at US$0.464 per share (20% discount to market) for aggregate proceeds of US$2,000,000. This is a classic private placement (PIPE) of unregistered equity securities relying on Section 4(a)(2) and Regulation S exemptions, materially dilutive to existing shareholders and a significant capital raise for the company.
View raw filing on EDGAR →Singularity Future Technology completed a private placement of 5,263,158 shares of common stock and 15,789,474 warrants to non-U.S. persons under Regulation S for approximately $2,000,000, closing on July 13, 2026. This unregistered equity issuance materially dilutes existing shareholders and signals capital-raising activity.
View raw filing on EDGAR →The 6-K discloses a registered direct offering completed on July 13, 2026, in which Haoxi issued 300,000 Class A ordinary shares at $0.40 per share and 9,700,000 pre-funded warrants (exercisable at $0.33) for gross proceeds of $4,000,000. This is a dilutive equity issuance that raises capital through the sale of registered securities, materially affecting share count and ownership structure. The disclosure explicitly states that 5,100,000 Class A shares were issued as of July 13, 2026, including shares from warrant exercises, representing a significant dilution to existing shareholders.
View raw filing on EDGAR →Planet Green Holdings entered into an ATM (at-the-market) Sales Agreement with Curvature Securities on July 13, 2026, authorizing the sale of up to approximately $8.9 million of common stock. This is a classic dilutive equity issuance under an ATM facility, which allows the company to raise capital by selling shares at market prices over time. The filing explicitly discloses the public float ($26.8 million) and the maximum offering amount under SEC Form S-3 rules, indicating material capital-raising activity that would dilute existing shareholders.
View raw filing on EDGAR →NXG Cushing Midstream Energy Fund entered into a distribution agreement authorizing the sale of up to 1,500,000 common shares through an at-the-market offering under Rule 415, and commenced a public offering of Common Shares on July 10, 2026 pursuant to its Registration Statement. This represents a material dilutive equity issuance that would affect existing shareholders through potential dilution.
View raw filing on EDGAR →The filing discloses a warrant inducement transaction in which Aptera issued 4,320,000 new unregistered warrants (the "Inducement Warrants") to holders who exercised existing warrants for $5.96 million in gross proceeds. Item 3.02 explicitly classifies this as an "Unregistered Sales of Equity Securities" under Section 4(a)(2) of the Securities Act. The issuance of dilutive equity securities in a private placement to raise capital is a hallmark dilutive_issuance event, particularly material for a small-cap company like Aptera (trading on Nasdaq Capital Market).
View raw filing on EDGAR →The filing discloses an unregistered sale of equity securities under Item 3.02: Beneficient issued 744,455 shares of Series B-11 Resettable Convertible Preferred Stock (convertible into up to 4,077,642 shares of Class A Common Stock) in exchange for a $7.44 million limited partner interest in an investment fund. The issuance was made in reliance on Section 4(a)(2) and Regulation D exemptions, and the press release notes that stockholder approval will be sought for issuances exceeding Nasdaq's Exchange Cap, indicating material dilution concerns typical of dilutive private placements.
View raw filing on EDGAR →Shareholders approved authorization for the Company to issue 20% or more of outstanding common stock at prices below NASDAQ minimum, and automatic conversion of convertible debentures totaling $6,825,400 principal plus interest into 6,841.33 shares of Series B Convertible Preferred Stock was triggered, materially affecting ownership structure and voting power.
View raw filing on EDGAR →Future Vision II Acquisition Corp. disclosed an unregistered sale of equity securities in the form of Units issuable upon conversion of a promissory note held by the Sponsor, subject to transfer restrictions until completion of the business combination and carrying registration rights.
View raw filing on EDGAR →Air T, Inc. entered into an At the Market Offering Agreement with Ascendiant Capital Markets to offer and sell up to $8,000,000 of common stock under a registered shelf registration statement (Form S-3). The company filed a prospectus supplement to facilitate the ATM offering, which constitutes a material dilutive equity issuance.
View raw filing on EDGAR →Freedom Holding Corp. completed an unregistered sale of 2,374,356 shares of common stock for approximately US$300 million pursuant to Regulation S, an offshore exemption from Securities Act registration. This dilutive equity issuance raises substantial capital outside the U.S. market and is material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →The filing discloses an At The Market (ATM) offering agreement entered into on March 10, 2025, under which Traws Pharma may offer and sell up to $5,575,709 of common stock shares through Citizens JMP Securities pursuant to an effective Form S-3 shelf registration and prospectus supplement dated July 10, 2026. This is a classic dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a key capital-raising mechanism commonly disclosed under Item 8.01 or Item 3.02.
View raw filing on EDGAR →Simultaneously with the IPO closing, the Sponsor and Representatives purchased 665,000 units (consisting of Class A ordinary shares and warrants) for $6.65 million in an unregistered private placement exempt from registration under Section 4(a)(2) of the Securities Act. This transaction represents significant dilution to public shareholders in the newly public blank-check company.
View raw filing on EDGAR →Cue Biopharma entered into a Securities Purchase Agreement on July 9, 2026, to issue 1,418,071 shares of common stock at $33.21 per share and pre-funded warrants to purchase 87,500 additional shares in a private placement, raising approximately $50.0 million from accredited investors including Cormorant Asset Management and Columbia Threadneedle Investments under Section 4(a)(2) and Rule 506 exemptions.
View raw filing on EDGAR →La Rosa Holdings entered into a Securities Purchase Agreement on July 10, 2026, to issue 250 shares of Series E Convertible Preferred Stock at $1,000 per share to an institutional investor under Rule 506(b) of Regulation D. The Series E Preferred Stock carries conversion rights into common stock at a conversion price of $1.58 per share with anti-dilution provisions, materially affecting existing shareholders through conversion and dilution mechanics.
View raw filing on EDGAR →Cyabra completed a $6.0 million private placement on July 9, 2026, issuing 1,175,090 common shares, pre-funded warrants to purchase 12,643,680 shares, and Series A and B warrants to purchase 13,818,770 shares each, together with conversion of 35.6 million preferred shares into common stock equivalents and exchange of $10.66 million in Series C preferred stock for private placement securities. The transaction substantially dilutes existing shareholders through unregistered equity issuance under Section 4(a)(2) and Regulation D, with significant warrant overhang representing a material capital structure adjustment.
View raw filing on EDGAR →The 6-K discloses a $1 million unregistered securities issuance under Section 4(a)(2) and Regulation D Rule 506(b), consisting of 1,000 convertible preferred shares and 1,089,918 ordinary warrants. This is a dilutive private placement to a single investor (Alpha Capital Anstalt) that will increase outstanding share count and dilute existing shareholders upon conversion and warrant exercise. The filing explicitly notes anti-dilution adjustments affecting previously issued preferred shares, indicating material capital structure impact.
View raw filing on EDGAR →This exhibit is a Securities Purchase Agreement dated July 10, 2026, under which VisionSys AI Inc is offering up to $91,750,000 of Ordinary Shares (represented by ADSs) at USD 0.000734 per share to multiple purchasers. The agreement explicitly relies on Section 4(a)(2) of the Securities Act and Regulation S exemptions from registration, indicating an unregistered private placement. This is a material dilutive issuance of equity securities to raise capital outside the registered public market.
View raw filing on EDGAR →Helport AI entered into an at-the-market (ATM) sales agreement with Lake Street Capital Markets on July 10, 2026, permitting the company to offer and sell up to $9,550,000 of ordinary shares. This is a dilutive equity issuance under Rule 415(a)(4) of the Securities Act, structured as an ATM offering. The agreement grants the sales agent a 3.0% commission and customary indemnification rights, and the shares are registered under Form F-3 (Registration Number 333-294622). Such capital-raising activities are material to investors assessing the registrant's financing strategy and potential shareholder dilution.
View raw filing on EDGAR →The filing discloses entry into a letter agreement modifying a Common Stock Purchase Agreement with Roth Principal Investments dated June 30, 2026. The adjustment of the purchase price discount to 5.0% of VWAP for pre- and post-market purchases indicates a private equity investment involving issuance of common stock at a discount to market price. This is a classic dilutive issuance structure typical of PIPE or equity financing arrangements, material to investors assessing capital structure and shareholder dilution.
View raw filing on EDGAR →The filing discloses the consummation of Viking Acquisition Corp. II's initial public offering on July 6, 2026, involving the issuance of 23,000,000 units at $10.00 per unit ($230 million gross proceeds) and 610,000 private placement units ($6.1 million gross proceeds). While this is technically an IPO rather than a private placement, the core event is the creation of new equity securities (units, ordinary shares, and warrants) that dilute existing shareholders. The private placement component (610,000 units to the Sponsor and underwriter Cohen) is explicitly unregistered under Section 4(a)(2) of the Securities Act, fitting the dilutive_issuance category. The IPO itself, though registered, represents a material capital-raising event through equity issuance.
View raw filing on EDGAR →Silo Pharma entered into securities purchase agreements on July 9, 2026, for a private placement of 619,965 shares of common stock (or pre-funded warrants), Series A-3 and A-4 warrants, raising approximately $4 million upfront with potential additional proceeds of ~$7.7 million upon warrant exercise. The unregistered securities were issued under Section 4(a)(2) and Regulation D exemptions, with a registration rights agreement for resale.
View raw filing on EDGAR →The Company exchanged 1,134 shares of Series B Preferred Stock (aggregate stated value $1,134,000) for 8,203,075 shares of common stock in unregistered transactions with Streeterville Capital, LLC on July 8-9, 2026, conducted under Section 3(a)(9) exemption. This is a classic dilutive equity issuance that materially increases common share count and would significantly affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →Jones Soda issued 7.5 million units at $0.33 per unit for $2.5 million in aggregate gross proceeds, with each unit comprising one common share and one-half warrant. The filing explicitly discloses this under Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), and the units were sold to accredited investors under Rule 506(b) and to non-U.S. persons under Regulation S—classic private placement mechanics. The company also announced a concurrent non-brokered offering of up to 2.3 million additional units for $765,000. This is a dilutive equity issuance raising capital through unregistered securities.
View raw filing on EDGAR →This exhibit is Form 45-106F1, a Canadian "Report of Exempt Distribution" template used to disclose private placements and exempt offerings of securities. The form's structure and instructions indicate it is filed to report distributions of securities (shares, notes, warrants, etc.) made under exemptions from prospectus requirements in Canadian securities law. While the exhibit shown is the blank form template rather than a completed report with specific transaction details, its presence as an exhibit to a 6-K filing by Avricore Health indicates the company has conducted or is reporting an exempt distribution—a dilutive issuance of equity or debt securities outside registered public offerings. This is material to investors as it affects share dilution and capital structure.
View raw filing on EDGAR →The Warrant Amendment materially reduces the exercise price from $16.00 to $1.50 per share for a 30-day period, creating a significant dilutive incentive for the investor to exercise and acquire common stock at a substantially discounted price. This amendment to an existing warrant arrangement effectively facilitates a dilutive equity issuance, as the reduced exercise price makes exercise highly attractive and increases the likelihood of share dilution to existing shareholders.
View raw filing on EDGAR →Ocean Thermal Energy Corp. authorized and issued Series E Preferred Stock, a convertible security, to raise capital. Two shares were sold to private investors for $20,000 in aggregate under Section 4(a)(2) and Regulation D exemptions, with authorization for up to 150 shares totaling $1.5 million. The preferred shares are convertible into common stock upon specified triggering events, materially diluting existing shareholders' ownership.
View raw filing on EDGAR →The filing discloses an unregistered sale of 9,232,047 shares of common stock pursuant to a Securities Purchase Agreement with C/M Capital Master Fund, LP, generating $1,265,063 in gross proceeds. The transaction was conducted under Section 4(a)(2) and Rule 506(b) exemptions, with the purchaser's resales subsequently registered on Form S-1. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of share ownership and capital structure.
View raw filing on EDGAR →Origin Materials issued one share of Series A Junior Preferred Stock to General Counsel Joshua Lee for $0.01 per share in an unregistered transaction. The issuance represents a material capital structure change, particularly given the Company's prior announcement of a Plan of Dissolution, and the preferred stock carries liquidation preferences senior to common stock.
View raw filing on EDGAR →Vivakor issued 3,740,586 shares of restricted common stock to Series A Preferred Stock holders as a dividend payment, including 1,445,349 shares to entities controlled by the CEO. The unregistered issuance is exempt under Section 4(a)(2) and materially dilutes existing shareholders.
View raw filing on EDGAR →Thunder Mountain Gold announced a non-brokered private placement of up to 9,143,000 units (each comprising one common share and one-half warrant) at US$0.70 per unit, raising approximately US$6.4 million in gross proceeds under Regulation D, together with a concurrent debt-for-equity settlement involving issuance of 1,578,036 common shares at the same price to settle US$1.1 million in outstanding compensation and debt including a related-party transaction with the CEO.
View raw filing on EDGAR →Rivian entered into an underwriting agreement on July 7, 2026 to issue 75 million shares of Class A common stock at $15.50 per share, with underwriters exercising a full 11.25 million share overallotment option on July 8, 2026. The offering generated approximately $1.32 billion in net proceeds for general corporate purposes and DOE loan facility equity contributions. This is a material registered public offering of equity securities that dilutes existing shareholders and raises substantial capital.
View raw filing on EDGAR →FuelCell Energy announced an underwritten public offering of 10,714,286 shares of common stock at $21.00 per share, generating gross proceeds of $225 million. This is a registered direct equity issuance that dilutes existing shareholders. The company intends to use proceeds for capital expenditures, working capital, and general corporate purposes. The magnitude ($225 million) and dilutive nature of the offering make it material to investors assessing the registrant's capital structure and ownership.
View raw filing on EDGAR →The Company entered into a subscription agreement on July 9, 2026 to issue 1,280,000 ordinary shares at $0.52 per share for $665,600 to an existing shareholder (ANRUITAI INVESTMENT LIMITED). The shares are being issued in an unregistered offshore transaction under Regulation S, which is a classic private placement (PIPE). This dilutive issuance is material as it increases outstanding shares from approximately 31.8 million to 33.1 million and raises capital for the registrant.
View raw filing on EDGAR →IperionX announced the pricing of a public offering of 2,275,000 ADSs (representing 22,750,000 ordinary shares) at $21.98 per ADS for approximately $50 million in gross proceeds. This is a registered public offering of equity securities that will dilute existing shareholders. The disclosure explicitly states the offering is being made pursuant to a shelf registration statement on Form F-3, making this a registered dilutive issuance material to investors assessing ownership and capital structure.
View raw filing on EDGAR →The press release announces the issuance of approximately 15.7 million new warrants (New EIB Warrants) to the European Investment Bank at €0.01 per warrant, representing approximately 6.5% of the Company's current share capital on a non-diluted basis. This is a dilutive equity issuance that would materially affect shareholder ownership and voting rights. The transaction is part of a broader refinancing and capital structure optimization, and the warrants are exercisable from August 30, 2026 through January 4, 2036, creating future dilution potential.
View raw filing on EDGAR →This announcement discloses a Share Purchase Plan (SPP) — an equity offering to shareholders — with an updated timetable following ASX waiver approvals. SPPs are a form of direct equity issuance that dilutes existing shareholders. The announcement confirms the Company has received waivers from ASX Listing Rules 7.1 and 10.11 and provides revised closing and allotment dates, indicating a material capital-raising activity that would affect investor assessment of share dilution and capital structure.
View raw filing on EDGAR →The Company amended a securities purchase agreement and convertible promissory note with Welle Environmental, revising anti-dilution provisions to establish a US$1.30 per-share floor price for equity and convertible securities issuances, with limited exceptions. This amendment reflects negotiation of dilution protections for the investor and indicates an underlying dilutive equity or convertible issuance transaction that materially affects shareholder interests.
View raw filing on EDGAR →Freedom Metals Acquisition Corp. consummated its initial public offering on July 9, 2026, issuing 27,500,000 units at $10.00 per unit for gross proceeds of $275 million, together with a concurrent private placement of 825,000 units to the Sponsor, Cohen, and CS at the same price for $8.25 million in gross proceeds.
View raw filing on EDGAR →Osprey Acquisition Corp. III consummated an initial public offering of 30,015,000 units at $10.00 per unit on July 2, 2026, generating $300,150,000 in gross proceeds, plus a simultaneous private placement of 747,000 units for $7,470,000. This is a material capital-raising event involving the issuance of equity securities (Class A ordinary shares and warrants) to public and private investors. While this is technically a SPAC IPO rather than a traditional dilutive issuance to existing shareholders, the event represents a substantial unregistered or newly-registered equity issuance that materially affects the company's capitalization and is reportable under Item 8.01.
View raw filing on EDGAR →This press release announces the pricing of a public offering of 8,000,000 units at $0.79 per unit, generating approximately $6.32 million in gross proceeds. Each unit comprises one Class A ordinary share and one warrant, representing a dilutive equity issuance. The offering is registered on Form F-1 and is material to investors as it significantly increases share count and dilutes existing shareholders.
View raw filing on EDGAR →Dreamland Limited entered into a securities purchase agreement on July 7, 2026, to issue 580,000 Class A ordinary shares and 72,000 Class B ordinary shares to Ms. Seto Wai Yue (a director and CEO) for US$2,445,000 in aggregate gross proceeds. The shares are unregistered and issued in reliance on Regulation S as an offshore transaction to a non-U.S. person. This is a classic private placement of equity securities by a foreign private issuer, materially dilutive to existing shareholders and raising capital through an unregistered issuance.
View raw filing on EDGAR →